[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.128.52. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Other Articles
January 8, 1938

CLINICAL EXPERIENCE WITH PROTAMINE ZINC INSULIN

Author Affiliations

ROCHESTER, MINN.

From the Division of Medicine, the Mayo Clinic.

JAMA. 1938;110(2):92-96. doi:10.1001/jama.1938.02790020006003
Abstract

Regular insulin has been used in the treatment of diabetes for about a decade and a half. The great improvement that it brought about in the treatment of diabetes was apparent at once. Its limitations as a substitute for the normal, functioning islands of Langerhans were gradually becoming more apparent during the last half of this time. These limitations were rarely stressed, and probably rightly so, in medical literature until the recent introduction of protamine insulin. A number of reports on the therapeutic results obtained with protamine insulin and with protamine zinc insulin have appeared in the literature. These reports, by necessity, have been made on the basis of a limited number of patients treated over a limited period. The tenor of the reports has, in general, been favorable to the use of protamine insulin and protamine zinc insulin. At present there are insufficient data to warrant detailed statistical analyses

First Page Preview View Large
First page PDF preview
First page PDF preview
×